about
Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profileTen putative contributors to the obesity epidemicThe role of monoamine oxidase inhibitors in current psychiatric practiceAdd-on topiramate reduces weight in overweight patients with affective disorders: a clinical case seriesThe Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesityQuantitative assessment of the bidirectional relationships between diabetes and depression.Metabolic Effects of Antidepressant TreatmentAssociations between anxiety, depression, antidepressant medication, obesity and weight gain among Canadian womenA generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapyDesvenlafaxine and weight change in major depressive disorderTolerability and safety of fluvoxamine and other antidepressants.Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder.Long-term body weight outcomes of antidepressant-environment interactionsDepression as a disease of modernity: explanations for increasing prevalence.Rediscovering trazodone for the treatment of major depressive disorderAssociation between change in depression and change in weight among women enrolled in weight loss treatment.Psychotropic-induced weight gain and potential pharmacologic treatment strategies.Weight-gain in psychiatric treatment: risks, implications, and strategies for prevention and management.Weight gain, obesity, and psychotropic prescribing.Receipt of nutrition and exercise counseling among medical outpatients with psychiatric and substance use disorders.Antidepressant use and diabetes mellitus risk: a meta-analysis.Neurocognitive functioning and health-related behaviours in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009-2010 National Health and Nutrition Examination Survey (NHANES)Repeated mirtazapine nullifies the maintenance of previously established methamphetamine-induced conditioned place preference in rats.Toward achieving optimal response: understanding and managing antidepressant side effectsA consensus statement for safety monitoring guidelines of treatments for major depressive disorder.Glucose tolerance in patients with narcolepsy.Light therapy for better mood and insulin sensitivity in patients with major depression and type 2 diabetes: a randomised, double-blind, parallel-arm trialObesogens, stem cells and the developmental programming of obesity.Association between depressive symptoms, use of antidepressant medication and the metabolic syndrome: the Maine-Syracuse Study.Taking the Perspective that a Depressive State Reflects Inflammation: Implications for the Use of AntidepressantsDepressive symptoms are associated with weight gain among women.Comparing the effects of fluoxetine and imipramine on total cholesterol, triglyceride, and weight in patients with major depression.Prevalence and correlates of eating disorder co-morbidity in patients with bipolar disorder.Examining a bidirectional association between depressive symptoms and diabetes.Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial.Cognitive Food Processing in Binge-Eating Disorder: An Eye-Tracking Study.Physical Exercise for Treatment of Mood Disorders: A Critical Review.Does body mass index moderate the association between posttraumatic stress disorder symptoms and suicidal ideation in Iraq/Afghanistan veterans?
P2860
Q21245293-83B09D19-6650-484D-B09B-E1F8C4E45ACEQ24619245-216B5D7A-0A36-422F-8138-C067CDE28FB2Q24679460-BDED2F0E-EA54-4178-83D6-264AFBA3E5B7Q24793223-F425325C-2474-499E-82A6-89704B22F57BQ28082434-18F7C5DE-A7F2-4481-BC8C-2418C602B418Q28307782-EB388BE1-10E5-4EC6-8B7B-215DC894765BQ33618693-01F057F2-8E1C-45B3-8381-C629AAC36343Q33712365-BEAD4D60-7AB8-4A7A-A89B-61558F1DAFFEQ33763331-273A9DE8-440F-44FF-971B-9C910C7E3926Q33884174-60513B79-8D22-4B20-B5DE-42DD6DE522B4Q33902252-817900F8-7536-4EC5-A345-30229C894C6EQ33995120-F46AD22D-2243-4DFF-A55C-F03FE5A6B74DQ34027230-7BB9D160-AF03-4EED-9512-F7DF4D540EE0Q34153588-92B50AB9-5F64-4EF5-8EB1-9F1ADD50DFCFQ34246950-9B5BEB30-19AF-46D9-A199-D5592E5BEFC4Q34314280-724E8F9C-A712-429A-BB91-29FB636A9946Q34363282-1A5BFB79-313D-4044-9E36-73E0EF7048E7Q34418639-B1C3B301-CD7B-4562-BF9F-1DB3155A9BD9Q34543946-FF29AACD-D14D-45D8-A241-3EDD86F2FEC1Q34557537-1F050458-BE1C-4129-9411-8DBB0F7DA25AQ34743193-A3117A62-314C-4011-BF50-7C7D077BED4CQ34886547-40E6C757-1065-4973-934E-AE44113D020CQ35012032-20B7A529-925A-4AB6-84D3-8614B1932229Q35023431-08BA82CE-1BD3-420A-9515-EB3558B9FF91Q35206777-F4AA3F26-2A93-4218-9476-815E05A1971DQ35237051-039DCD9E-69E1-4096-B4D5-72837AD26233Q35311467-78BAC53B-AC79-482A-AF65-F02728D4AF9FQ35648378-569D9A6F-45FF-4817-B10B-9D52B2C061E2Q35708823-F19F4245-0A1D-41E0-97E8-B783C692A2CAQ35980782-90199AE3-B8CB-4DBF-BB50-CA213656D368Q36048775-3E917F65-D405-4A3E-974A-2222CE84F15DQ36171115-B0F37138-9AEE-4D41-8213-875858108B06Q36227338-06A411CA-6916-48E9-87E0-472063A5DC11Q36565050-A75498E3-7223-448A-87A7-9739C2EED458Q37098549-2CFDD1F3-D904-4280-82DD-F174E0929EE8Q37111643-4E65F84D-B42B-4949-AD35-A2CDBCA5710EQ38383926-89AF201D-6CC6-4E70-AE7B-F8D302EA1AD9Q38616319-C6B8B9A6-E1E4-4646-9A9E-D8B3A8D855EBQ38684018-14658E35-E367-4251-A227-641D3C2E7331Q39538416-63A34A48-89CD-44AB-A571-CEDB0FD23B38
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Weight gain and antidepressants.
@ast
Weight gain and antidepressants.
@en
type
label
Weight gain and antidepressants.
@ast
Weight gain and antidepressants.
@en
prefLabel
Weight gain and antidepressants.
@ast
Weight gain and antidepressants.
@en
P1476
Weight gain and antidepressants.
@en
P2093
P478
61 Suppl 11
P577
2000-01-01T00:00:00Z